Showing results (371-380 of 391) with videos related to

Sort By:
Pageof 40
Plos Neglected Tropical Diseases|October 1, 2021
Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in GabonYoanne D Mouwenda, Madeleine E Betouke Ongwe, Friederike Sonnet, et al.
Nature Communications|July 24, 2025
T cell responses in repeated controlled human schistosome infection compared to natural exposureEmmanuella Driciru, Jan Pieter R Koopman, Sanne Steenbergen, et al.
Science Translational Medicine|June 5, 2024
Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degenerationMarvin Reich, Matthew J Simon, Beate Polke, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Alterations in Lysosomal, Glial and Neurodegenerative Biomarkers in Patients with Sporadic and Genetic Forms of Frontotemporal DementiaJennifer Hsiao-Nakamoto, Chi-Lu Chiu, Lawren VandeVrede, et al.
Neuron|January 7, 2020
TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic ChallengeAlicia A Nugent, Karin Lin, Bettina van Lengerich, et al.
Molecular Neurodegeneration|August 7, 2025
LRRK2 kinase activity regulates Parkinson's disease-relevant lipids at the lysosomeMichael T Maloney, Xiang Wang, Rajarshi Ghosh, et al.
European Journal of Endocrinology|July 15, 2011
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomasMaria A Tichomirowa, Anne Barlier, Adrian F Daly, et al.
Elife|September 17, 2024
DNL343 is an investigational CNS penetrant eukaryotic initiation factor 2B activator that prevents and reverses the effects of neurodegeneration caused by the integrated stress responseErnie Yulyaningsih, Jung H Suh, Melania Fanok, et al.
Limnology and Oceanography|October 17, 2022
Machine learning techniques to characterize functional traits of plankton from image dataEric C Orenstein, Sakina-Dorothée Ayata, Frédéric Maps, et al.
Science Translational Medicine|June 8, 2022
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's diseaseDanna Jennings, Sarah Huntwork-Rodriguez, Anastasia G Henry, et al.
Pageof 40